AILERON THERAPEUTICS INC
Pagina dedicata companiei AILERON THERAPEUTICS INC listata cu simbolul US.ALRN
Descriere companie
Aileron Therapeutics, Inc. (www.aileronrx.com) is a clinical-stage chemoprotection oncology company. The Company is focused on transforming the experience of chemotherapy for cancer patients. It is developing ALRN-6924, which is their dual Mouse double minute 2 homolog (MDM2) and MDMX inhibitor to provide a single medicine to protect multiple healthy cell types throughout the body from chemotherapy while ensuring chemotherapy continues to destroy cancer cells. ALRN-6924 acts as an agent to reduce the toxic side effects of chemotherapy in the bone marrow of cancer patients without adversely impacting the anti-cancer activity of chemotherapy against p53-mutant tumors.
Grafic actiuni companie